ISR 0.00 Isoray, Inc.
| Range: | 0.19-0.45 | Vol Avg: | 280832 | Last Div: | 0 | Changes: | 0 |
| Beta: | 0 | Cap: | 0.00B | Currency: | USD | Exchange: | AMEX |
| Sector: | Healthcare | IPO: | Fri May 31 2002 | Empoloyees: | 66 | ||
| CUSIP: | 46489V104 | CIK: | 0000728387 | ISIN: | US46489V1044 | Country: | US |
| CEO: | Ms. Lori A. Holmes-Woods | Website: | https://isoray.com | ||||
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
Stock Details
Positive 0.39
Uranium Energy Corp Files Fiscal 2024 Annual Report
NYSE American: UEC Transformative Year with Wyoming ISR Production Restart, 100% Unhedged ...
prnewswire.com·Fri Sep 27 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow